A detailed history of Braidwell LP transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Braidwell LP holds 2,560,573 shares of XENE stock, worth $115 Million. This represents 3.13% of its overall portfolio holdings.

Number of Shares
2,560,573
Previous 1,308,011 95.76%
Holding current value
$115 Million
Previous $56.3 Billion 77.3%
% of portfolio
3.13%
Previous 1.81%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$36.25 - $43.75 $45.4 Million - $54.8 Million
1,252,562 Added 95.76%
2,560,573 $99.8 Billion
Q1 2024

May 15, 2024

SELL
$42.66 - $50.04 $14.5 Million - $17 Million
-339,300 Reduced 20.6%
1,308,011 $56.3 Billion
Q4 2023

Feb 14, 2024

SELL
$28.7 - $46.46 $13.1 Million - $21.2 Million
-456,085 Reduced 21.68%
1,647,311 $75.9 Billion
Q3 2023

Nov 14, 2023

BUY
$34.16 - $39.73 $9.4 Million - $10.9 Million
275,043 Added 15.04%
2,103,396 $71.9 Billion
Q2 2023

Aug 14, 2023

SELL
$34.84 - $43.54 $10.8 Million - $13.4 Million
-308,757 Reduced 14.45%
1,828,353 $70.4 Billion
Q1 2023

May 15, 2023

BUY
$33.46 - $40.35 $19.7 Million - $23.8 Million
589,000 Added 38.05%
2,137,110 $76.5 Billion
Q4 2022

Feb 14, 2023

BUY
$33.06 - $39.43 $51.2 Million - $61 Million
1,548,110 New
1,548,110 $61 Billion

Others Institutions Holding XENE

About Xenon Pharmaceuticals Inc.


  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.8B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Braidwell LP Portfolio

Follow Braidwell LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Braidwell LP, based on Form 13F filings with the SEC.

News

Stay updated on Braidwell LP with notifications on news.